Accretive Health (ACHI) 1.8700 $ACHI
Accretive Health Announces Restructuring Plan to Align to Customer Needs and Support Committed Growth
GlobeNewswire - Wed Jun 29, 3:30PM CDT
Accretive Health, Inc. (OTC Pink:ACHI) ("Accretive Health" or the "Company"
today announced a restructuring plan to align its workforce to best position the Company for its already committed future growth. The plan is part of a company-wide review centered around three key priorities: ensure the Company can efficiently deliver on already contracted demand; improve the organizational design to better align with customer needs and further improve performance; and drive internal corporate and operating efficiency. Specific changes include adjusting internal functions, processes and organizational structure, with the associated reduction driven primarily in SG&A expense categories.
Air Methods Announces New Chief Financial Officer
GlobeNewswire - Wed Jun 01, 3:01PM CDT
Air Methods Corporation (Nasdaq:AIRM) announced that Peter Csapo will join America's largest air medical provider and helicopter operator as chief financial officer (CFO). Csapo will begin his new role effective June 6, succeeding Trent Carman who will be stepping down from his role of more than 13 years.
AIRM: 37.82 (+1.16), MCK: 192.79 (+1.59)
Accretive Health Appoints Joseph Flanagan President and CEO
GlobeNewswire - Thu May 26, 7:00AM CDT
Accretive Health, Inc. (OTC Pink:ACHI) today announced that its Board of Directors has appointed Joseph Flanagan, currently President and Chief Operating Officer of Accretive Health, as President, Chief Executive Officer and member of the Board, effective immediately. Dr. Emad Rizk and the Board of Directors have mutually agreed for Dr. Rizk to step down from his positions as CEO and member of the Board. Dr. Rizk will be available over the next several weeks to help ensure a smooth transition.
Accretive Health CEO Emad Rizk featured panelist at Becker's Hospital Review 7th Annual Meeting
GlobeNewswire - Fri May 13, 8:30AM CDT
Accretive Health (OTC Pink:ACHI) Chief Executive Officer, Emad Rizk, M.D., was a featured panelist at the 7th Annual Becker's Hospital Review Meeting. This industry-leading conference was held at the Hyatt Regency in Chicago, IL from April 27-30, 2016. Dr. Rizk joined an esteemed panel of c-level hospital and health system executives to discuss "The Best Actions to Improve Revenue Now: What is Working."
Accretive Health Reports First Quarter 2016 Results
GlobeNewswire - Tue May 10, 4:06PM CDT
Accretive Health, Inc. (OTC Pink:ACHI), a leading provider of revenue cycle services and physician advisory services to healthcare providers, today announced results for the quarter ended March 31, 2016.
Accretive Health to Release First Quarter 2016 Results on May 10
GlobeNewswire - Tue Apr 26, 7:00AM CDT
Accretive Health, Inc. (OTC Pink:ACHI) today announced it expects to release its financial results for the three months ended March 31, 2016 after market close on Tuesday, May 10, 2016.
Accretive Health Announces Management Changes to Position Company Post-Transaction for Growth Phase
BusinessWire - Thu Apr 21, 3:30PM CDT
--Christopher Ricaurte promoted to Chief Financial Officer and Treasurer
Glancy Prongay & Murray LLP Announces Proposed Settlement of Accretive Health, Inc. Securities Litigation
PR Newswire - Thu Apr 14, 10:30AM CDT
The following statement is being issued by Glancy Prongay & Murray LLP regarding the Accretive Health, Inc. Securities Litigation:
New Strong Sell Stocks for April 11th
Zacks Equity Research - Zacks Investment Research - Mon Apr 11, 9:04AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Monday
AVP: 3.93 (+0.19), ANW: 5.90 (+0.40), CAR: 34.61 (+3.71), AIR: 23.32 (+0.60)
Accretive Health Reports Fourth Quarter 2015 and Full-Year Results
GlobeNewswire - Thu Mar 10, 3:04PM CST
Accretive Health, Inc. (OTC Pink:ACHI), a leading provider of revenue cycle services and physician advisory services to healthcare providers, today announced results for the quarter and year ended December 31, 2015.
Traders Look to Upside - Analyst Research on SandRidge Energy, Elite Pharmaceuticals, Dyadic International and Accretive Health
ACCESSWIRE - Thu Jan 21, 8:34AM CST
NEW YORK, NY / ACCESSWIRE / January 21, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: SandRidge Energy Inc. (OTC: SDOC), Elite Pharmaceuticals Inc. (OTC: ELTP), Dyadic International Inc. (OTC: DYAI) and Accretive Health Inc. (OTC: ACHI). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
SD: 0.15 (-0.02)
Navigant Consulting (NCI) Worth a Look: Stock Rises 6.9%
Zacks Equity Research - Zacks Investment Research - Wed Jan 06, 7:45AM CST
Navigant Consulting Inc. (NCI) was a big mover last session, as the company saw its shares rise nearly 7% on the day.
NCI: 16.75 (+0.47)
Navigant Boosts Healthcare Business on McKinnis Buyout
Zacks Equity Research - Zacks Investment Research - Tue Jan 05, 2:30PM CST
Navigant Consulting Inc. (NCI) recently announced the acquisition of McKinnis Consulting Services.
ASGN: 36.86 (+1.87), HCKT: 14.16 (+0.51), NCI: 16.75 (+0.47)
Global Healthcare RCM Outsourcing Market 2015-2019
M2 - Wed Dec 09, 4:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/blfwsf/global_healthcare) has announced the addition of the "Global Healthcare RCM Outsourcing Market 2015-2019" report to their offering. The healthcare industry is undergoing a transition with increased competition among healthcare service providers. Currently, companies are more focused on providing quality care at lower price to their patients. Increasing healthcare cost is an alarming concern in this industry. In order to achieve cost savings, the industry players have introduced significant innovations in non-clinical solutions such as simplified administrative costs. The administrative components comprise all the services that range from front-end to back-end services. The process starts from gathering information from patients, documentation record, submitting, analyzing, and eventually paying for medical bills. This whole spectrum of administrative services is considered as healthcare RCM. This new report forecasts the global healthcare RCM outsourcing market to grow at a CAGR of 17.55% over the period 2014-2019. The report covers the current scenario and the growth prospects of the global healthcare RCM outsourcing. It has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the landscape of the global healthcare RCM outsourcing and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. Key Topics Covered: PART:01 Executive summary PART:02 Scope of the report PART:03 Market research methodology PART:04 Introduction PART:05 Market landscape PART:06 Market segmentation by services PART:07 Market segmentation by end-user PART:08 Geographical segmentation PART:09 Market drivers PART:10 Impact of drivers PART:11 Market challenges PART:12 Impact of drivers and challenges PART:13 Market trends PART:14 Vendor landscape PART:15 Key vendor analysis 20 of over 40 Companies Mentioned: - - Conifer Health Solutions - - Emdeon Business Services - - MedAssets - - Parallon Business Solutions - - The SSI Group - - Account Control Technology - - Accretive Health - - ACS Healthcare Solutions - - Adreima - - Alleviant - - Avadyne Health - - BancTe - - Bolder Healthcare Solutions - - Cardon Outreach - - CCS Revenue Cycle - - Cerner - - Certive Solutions - - Conifer Health Solutions - - Constellation Healthcare Technologies - - edgeMED Healthcare Solutions For more information visit http://www.researchandmarkets.com/research/bl...healthcare
CERN: 60.62 (+1.01)
Accretive Health and Ascension Announce Long-Term Strategic Partnership
BusinessWire - Tue Dec 08, 6:00AM CST
--Ascension selects Accretive Health ("Accretive" as its exclusive hospital revenue cycle partner for a 10-year term
Analyst Insights behind Price Movement - Research on Lipocine, Syneron Medical, Republic Airways and Accretive Health
ACCESSWIRE - Tue Nov 24, 7:32AM CST
NEW YORK, NY / ACCESSWIRE / November 24, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Lipocine Inc (NASDAQ: LPCN), Syneron Medical Ltd. (NASDAQ: ELOS), Republic Airways Holdings Inc. (NASDAQ: RJET) and Accretive Health, Inc. (OTC: ACHI). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
ELOS: 7.45 (+0.06), RJET: 1.31 (+0.02), LPCN: 3.34 (+0.07)
Accretive Health President & CEO Emad Rizk featured panelist at Becker's Hospital Review 4th Annual CEO Roundtable + CFO/CIO Roundtable
BusinessWire - Mon Nov 23, 6:48PM CST
Accretive Health (OTC Pink: ACHI) President and Chief Executive Officer, Emad Rizk, M.D., was a featured panelist at the 4th Annual Becker's Hospital Review CEO Roundtable + CFO/CIO Roundtable. This industry-leading conference was held at the Ritz Carlton in Chicago, IL from November 18-19, 2015. Dr. Rizk joined an esteemed, all-CEO panel on "The Biggest Challenges and Opportunities for Hospitals and Health Systems".
Origins of Technical Movement, Pricing Tomorrow - Research on Lipocine, Syneron Medical, Republic Airways Holdings, and Accretive Health
ACCESSWIRE - Mon Nov 16, 7:31AM CST
NEW YORK, NY / ACCESSWIRE / November 16, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Lipocine Inc. (NASDAQ: LPCN), Syneron Medical Ltd (NASDAQ: ELOS), Republic Airways Holdings Inc. (NASDAQ: RJET) and Accretive Health Inc. (OTC: ACHI). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
ELOS: 7.45 (+0.06), RJET: 1.31 (+0.02), LPCN: 3.34 (+0.07)
Accretive Health Reports Third Quarter 2015 Results
BusinessWire - Mon Nov 09, 3:01PM CST
--Signed on a new revenue cycle customer with $700 million in net patient revenue in 3Q
Accretive Health Announces Restructuring Plan to Align to Customer Needs and Support Committed Growth
GlobeNewswire - Wed Jun 29, 3:30PM CDT
Accretive Health, Inc. (OTC Pink:ACHI) ("Accretive Health" or the "Company"
today announced a restructuring plan to align its workforce to best position the Company for its already committed future growth. The plan is part of a company-wide review centered around three key priorities: ensure the Company can efficiently deliver on already contracted demand; improve the organizational design to better align with customer needs and further improve performance; and drive internal corporate and operating efficiency. Specific changes include adjusting internal functions, processes and organizational structure, with the associated reduction driven primarily in SG&A expense categories. Air Methods Announces New Chief Financial Officer
GlobeNewswire - Wed Jun 01, 3:01PM CDT
Air Methods Corporation (Nasdaq:AIRM) announced that Peter Csapo will join America's largest air medical provider and helicopter operator as chief financial officer (CFO). Csapo will begin his new role effective June 6, succeeding Trent Carman who will be stepping down from his role of more than 13 years.
AIRM: 37.82 (+1.16), MCK: 192.79 (+1.59)
Accretive Health Appoints Joseph Flanagan President and CEO
GlobeNewswire - Thu May 26, 7:00AM CDT
Accretive Health, Inc. (OTC Pink:ACHI) today announced that its Board of Directors has appointed Joseph Flanagan, currently President and Chief Operating Officer of Accretive Health, as President, Chief Executive Officer and member of the Board, effective immediately. Dr. Emad Rizk and the Board of Directors have mutually agreed for Dr. Rizk to step down from his positions as CEO and member of the Board. Dr. Rizk will be available over the next several weeks to help ensure a smooth transition.
Accretive Health CEO Emad Rizk featured panelist at Becker's Hospital Review 7th Annual Meeting
GlobeNewswire - Fri May 13, 8:30AM CDT
Accretive Health (OTC Pink:ACHI) Chief Executive Officer, Emad Rizk, M.D., was a featured panelist at the 7th Annual Becker's Hospital Review Meeting. This industry-leading conference was held at the Hyatt Regency in Chicago, IL from April 27-30, 2016. Dr. Rizk joined an esteemed panel of c-level hospital and health system executives to discuss "The Best Actions to Improve Revenue Now: What is Working."
Accretive Health Reports First Quarter 2016 Results
GlobeNewswire - Tue May 10, 4:06PM CDT
Accretive Health, Inc. (OTC Pink:ACHI), a leading provider of revenue cycle services and physician advisory services to healthcare providers, today announced results for the quarter ended March 31, 2016.
Accretive Health to Release First Quarter 2016 Results on May 10
GlobeNewswire - Tue Apr 26, 7:00AM CDT
Accretive Health, Inc. (OTC Pink:ACHI) today announced it expects to release its financial results for the three months ended March 31, 2016 after market close on Tuesday, May 10, 2016.
Accretive Health Announces Management Changes to Position Company Post-Transaction for Growth Phase
BusinessWire - Thu Apr 21, 3:30PM CDT
--Christopher Ricaurte promoted to Chief Financial Officer and Treasurer
Glancy Prongay & Murray LLP Announces Proposed Settlement of Accretive Health, Inc. Securities Litigation
PR Newswire - Thu Apr 14, 10:30AM CDT
The following statement is being issued by Glancy Prongay & Murray LLP regarding the Accretive Health, Inc. Securities Litigation:
New Strong Sell Stocks for April 11th
Zacks Equity Research - Zacks Investment Research - Mon Apr 11, 9:04AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Monday
AVP: 3.93 (+0.19), ANW: 5.90 (+0.40), CAR: 34.61 (+3.71), AIR: 23.32 (+0.60)
Accretive Health Reports Fourth Quarter 2015 and Full-Year Results
GlobeNewswire - Thu Mar 10, 3:04PM CST
Accretive Health, Inc. (OTC Pink:ACHI), a leading provider of revenue cycle services and physician advisory services to healthcare providers, today announced results for the quarter and year ended December 31, 2015.
Traders Look to Upside - Analyst Research on SandRidge Energy, Elite Pharmaceuticals, Dyadic International and Accretive Health
ACCESSWIRE - Thu Jan 21, 8:34AM CST
NEW YORK, NY / ACCESSWIRE / January 21, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: SandRidge Energy Inc. (OTC: SDOC), Elite Pharmaceuticals Inc. (OTC: ELTP), Dyadic International Inc. (OTC: DYAI) and Accretive Health Inc. (OTC: ACHI). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
SD: 0.15 (-0.02)
Navigant Consulting (NCI) Worth a Look: Stock Rises 6.9%
Zacks Equity Research - Zacks Investment Research - Wed Jan 06, 7:45AM CST
Navigant Consulting Inc. (NCI) was a big mover last session, as the company saw its shares rise nearly 7% on the day.
NCI: 16.75 (+0.47)
Navigant Boosts Healthcare Business on McKinnis Buyout
Zacks Equity Research - Zacks Investment Research - Tue Jan 05, 2:30PM CST
Navigant Consulting Inc. (NCI) recently announced the acquisition of McKinnis Consulting Services.
ASGN: 36.86 (+1.87), HCKT: 14.16 (+0.51), NCI: 16.75 (+0.47)
Global Healthcare RCM Outsourcing Market 2015-2019
M2 - Wed Dec 09, 4:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/blfwsf/global_healthcare) has announced the addition of the "Global Healthcare RCM Outsourcing Market 2015-2019" report to their offering. The healthcare industry is undergoing a transition with increased competition among healthcare service providers. Currently, companies are more focused on providing quality care at lower price to their patients. Increasing healthcare cost is an alarming concern in this industry. In order to achieve cost savings, the industry players have introduced significant innovations in non-clinical solutions such as simplified administrative costs. The administrative components comprise all the services that range from front-end to back-end services. The process starts from gathering information from patients, documentation record, submitting, analyzing, and eventually paying for medical bills. This whole spectrum of administrative services is considered as healthcare RCM. This new report forecasts the global healthcare RCM outsourcing market to grow at a CAGR of 17.55% over the period 2014-2019. The report covers the current scenario and the growth prospects of the global healthcare RCM outsourcing. It has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the landscape of the global healthcare RCM outsourcing and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. Key Topics Covered: PART:01 Executive summary PART:02 Scope of the report PART:03 Market research methodology PART:04 Introduction PART:05 Market landscape PART:06 Market segmentation by services PART:07 Market segmentation by end-user PART:08 Geographical segmentation PART:09 Market drivers PART:10 Impact of drivers PART:11 Market challenges PART:12 Impact of drivers and challenges PART:13 Market trends PART:14 Vendor landscape PART:15 Key vendor analysis 20 of over 40 Companies Mentioned: - - Conifer Health Solutions - - Emdeon Business Services - - MedAssets - - Parallon Business Solutions - - The SSI Group - - Account Control Technology - - Accretive Health - - ACS Healthcare Solutions - - Adreima - - Alleviant - - Avadyne Health - - BancTe - - Bolder Healthcare Solutions - - Cardon Outreach - - CCS Revenue Cycle - - Cerner - - Certive Solutions - - Conifer Health Solutions - - Constellation Healthcare Technologies - - edgeMED Healthcare Solutions For more information visit http://www.researchandmarkets.com/research/bl...healthcare
CERN: 60.62 (+1.01)
Accretive Health and Ascension Announce Long-Term Strategic Partnership
BusinessWire - Tue Dec 08, 6:00AM CST
--Ascension selects Accretive Health ("Accretive"
as its exclusive hospital revenue cycle partner for a 10-year term Analyst Insights behind Price Movement - Research on Lipocine, Syneron Medical, Republic Airways and Accretive Health
ACCESSWIRE - Tue Nov 24, 7:32AM CST
NEW YORK, NY / ACCESSWIRE / November 24, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Lipocine Inc (NASDAQ: LPCN), Syneron Medical Ltd. (NASDAQ: ELOS), Republic Airways Holdings Inc. (NASDAQ: RJET) and Accretive Health, Inc. (OTC: ACHI). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
ELOS: 7.45 (+0.06), RJET: 1.31 (+0.02), LPCN: 3.34 (+0.07)
Accretive Health President & CEO Emad Rizk featured panelist at Becker's Hospital Review 4th Annual CEO Roundtable + CFO/CIO Roundtable
BusinessWire - Mon Nov 23, 6:48PM CST
Accretive Health (OTC Pink: ACHI) President and Chief Executive Officer, Emad Rizk, M.D., was a featured panelist at the 4th Annual Becker's Hospital Review CEO Roundtable + CFO/CIO Roundtable. This industry-leading conference was held at the Ritz Carlton in Chicago, IL from November 18-19, 2015. Dr. Rizk joined an esteemed, all-CEO panel on "The Biggest Challenges and Opportunities for Hospitals and Health Systems".
Origins of Technical Movement, Pricing Tomorrow - Research on Lipocine, Syneron Medical, Republic Airways Holdings, and Accretive Health
ACCESSWIRE - Mon Nov 16, 7:31AM CST
NEW YORK, NY / ACCESSWIRE / November 16, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Lipocine Inc. (NASDAQ: LPCN), Syneron Medical Ltd (NASDAQ: ELOS), Republic Airways Holdings Inc. (NASDAQ: RJET) and Accretive Health Inc. (OTC: ACHI). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
ELOS: 7.45 (+0.06), RJET: 1.31 (+0.02), LPCN: 3.34 (+0.07)
Accretive Health Reports Third Quarter 2015 Results
BusinessWire - Mon Nov 09, 3:01PM CST
--Signed on a new revenue cycle customer with $700 million in net patient revenue in 3Q
